The 78th Annual Meeting of the Japanese Cancer Association

Call for Abstract
(Abbreviations for affiliated institutions)


  • 1 Chemical carcinogenesis and radiation carcinogenesis

    1-1 Activation and metabolism of carcinogens
    1-2 Detection and assessment of carcinogens
    1-3 DNA damage
    1-4 Process of carcinogenesis
    1-5 Nitric oxide/reactive oxygen
    1-6 Genotoxins and nongenotoxins
    1-7 Experimental cell culture systems
    1-8 Radiation and electromagnetic wave carcinogenesis
    1-9 Others

    2 Experimental animal models and genetically-engineered animals

    2-1 Gene-manipulated animal models
    2-2 Animal model for carcinogenesis
    2-3 Others

    3 Virus, infection, inflammation and cancer

    3-1 EBV
    3-2 HPV
    3-3 HBV
    3-4 HCV
    3-5 HTLV-1
    3-6 HHV-8
    3-7 H.pylori
    3-8 Other viruses/bacteria
    3-9 Inflammation and cancer

    4 Oncogenes and tumor-suppressor genes

    4-1 ras family genes
    4-2 p53-related genes
    4-3 Rb/p16-related genes
    4-4 Wnt signaling-related genes
    4-5 Chromosomal translocation-related genes
    4-6 Other oncogenes/
    tumor-suppressor genes
    4-7 Novel oncogenes/
    tumor-suppressor genes

    5 Signal transduction and gene expression

    5-1 Proliferation/differentiation
    5-2 Signal transduction
    5-3 Transcriptional regulation
    5-4 Translational regulation
    5-5 RNA engineering
    5-6 micro-RNA
    5-7 Others

    6 DNA replication/cell cycle/genomic instability

    6-1 Cell cycle/checkpoint
    6-2 DNA replication
    6-3 DNA repair
    6-4 Genetic instability

    7 Cancer genome/genetics

    7-1 Genomic analysis
    7-2 Homozygous deletion/positional cloning
    7-3 Chromosomal translocation/gene rearrangement
    7-4 Gene amplification
    7-5 Familial tumor and target genes
    7-6 Carcinogenic sensitivity-related genes (SNPs)
    7-7 Others

    8 Cell death/immortalization

    8-1 Cell death
    8-2 Telomeres/senescence
    8-3 Others

    9 Epigenetics

    9-1 DNA methylation
    9-2 Histone modification
    9-3 Chromatin structure
    9-4 Others

    10 Invasion and metastasis

    10-1 Cell adhesion/invasion
    10-2 Extracellular matrices and proteases
    10-3 Metastasis-associated genes
    10-4 Angiogenesis
    10-5 Diagnosis of metastasis
    10-6 Metastasis inhibition
    10-7 Metastasis models
    10-8 Others

    11 Characteristics of cancer cells

    11-1 Cancer stem cells
    11-2 Cell differentiation
    11-3 Cell-to-cell interaction/
    adhesion molecules
    11-4 Cell lines
    11-5 Carbohydrate chains and glycosyltransferases
    11-6 Metabolism / Metabolome
    11-7 Others

    12 Cancer immunity

    12-1 Innate immunity
    12-2 Dendritic cells/
    antigen-presenting cells
    12-3 Tumor antigens
    12-4 Antitumor effector cells and their induction
    12-5 Vaccination therapy
    12-6 Antibody therapy
    12-7 Other immunotherapies
    12-8 Others

    13 Growth factors/cytokines/
    hormones

    13-1 Growth- and differentiation-regulating factors
    13-2 Growth factor receptors
    13-3 Hormones
    13-4 Cytokines
    13-5 TGF-b/Smad

  • 14 Cancer basic, diagnosis and treatment

    14-1 Gastric cancer
    14-2 Esophageal cancer
    14-3 Colorectal cancer
    14-4 GIST
    14-5 Hepatocellular cancer
    14-6 Carcinoma of the biliary tract
    14-7 Pancreatic cancer
    14-8 Lung cancer
    14-9 Breast cancer
    14-10 Uterine cancer
    14-11 Ovarian cancer
    14-12 hematopoietic malignancy
    14-13 Renal cell cancer
    14-14 Bladder cancer
    14-15 Prostatic cancer
    14-16 Testicular cancer
    14-17 Brain tumor
    14-18 Primary bone tumor
    14-19 Soft tissue sarcoma
    14-20 Head and neck cancer
    14-21 Endocrine cancer
    14-22 Skin cancer
    14-23 Pediatric cancer
    14-24 Other organs

    15 Diagnosis

    15-1 Pathological diagnosis
    15-2 Diagnostic imaging
    15-3 Diagnosis by tumor markers and biomarkers
    15-4 Genetic diagnosis
    15-5 Diagnosis by expression analysis (mRNA, protein)
    15-6 Novel diagnostic technology
    15-7 Others

    16 Molecular-targeting therapy

    16-1 Signal transduction inhibitors/
    kinase inhibitors
    16-2 Angiogenesis inhibitors/
    antimetastatic drugs
    16-3 Cell cycle inhibitors (CDK inhibitors etc.)
    16-4 Transcription modulators (histone deacetylase inhibitors etc.)
    16-5 Others

    17 Chemotherapy and endocrine therapy

    17-1 Natural anticancer compounds
    17-2 Synthetic anticancer compounds
    17-3 DNA-damaging drug (Platinum compounds/Topoisomerase inhibitors etc.)
    17-4 Antimetabolites
    17-5 Antimicrotubular drugs (taxane/alkaloids etc.)
    17-6 Anticancer drug resistance
    17-7 Anticancer drug and cell death
    17-8 Endocrine therapy
    17-9 Differentiation-inducing therapy
    17-10 Drug delivery system
    17-11 Combinational therapy/adjuvant therapy
    17-12 Others

    18 Evaluation and prediction of pharmacological effects

    18-1 Drug sensitivity/drug resistance-relating factors/gene expression analysis
    18-2 Pharmacokinetics/pharmacodynamics (PK/PD)
    18-3 Pharmacogenomics/toxicogenomics (SNPs, transcriptome, proteome)
    18-4 Sensitivity test
    18-5 Clinical trial

    19 Radiation therapy

    19-1 Radiation and particle ray therapy
    19-2 Radiation hazard/protection
    19-3 Radiosensitivity
    19-4 Efficacy enhancement
    19-5 Hyperthermia
    19-6 Others

    20 Cell therapy and regeneration medicine

    20-1 Stem cells
    20-2 Regenerative medicine
    20-3 Cell therapy of allograft
    20-4 Others

    21 Gene therapy

    21-1 Generation and modification of vectors
    21-2 Immunogenetic therapy
    21-3 Oncogene/
    tumor-suppressor gene therapy
    21-4 Suicide gene therapy
    21-5 　
    21-6 Others

    22 Medical care of progressive cancer

    22-1 Psychooncology
    22-2 Palliative treatment and care
    22-3 Others

    23 Cancer prevention/chemoprevention

    23-1 Mechanism of cacinogenesis inhibition
    23-2 Synthetic compounds
    23-3 Natural products
    23-4 Dietary/alimentary factors
    23-5 Others

    24 Epidemiology

    24-1 Environmental factors (life habits etc.)/infectious exposure
    24-2 Cancer prone syndromes/
    molecular epidemiology
    24-3 Cohort study
    24-4 Descriptive epidemiology/
    cancer registration
    24-5 Cancer screening
    24-6 Others

    25 Information/informatics

    25-1 Bioinfomatics
    25-2 Management and analysis of cancer patients' data
    25-3 Others

    26 Cancer and society

    26-1 Informed consent
    26-2 Bioethics
    26-3 Social movement against cancer
    26-4 Smoking and drinking alcohol
    26-5 Others